Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of
significant global morbidity and mortality. Here, we review the literature to date of the short …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Abstract Background Coronavirus-like particles (CoVLP) that are produced in plants and
display the prefusion spike glycoprotein of the original strain of severe acute respiratory …

Importance Myocarditis has been reported with COVID-19 but is not clearly recognized as a
possible adverse event following COVID-19 vaccination. Objective To describe myocarditis …

Background: Acute myocarditis (AM) is thought to be a rare cardiovascular complication of
COVID-19, although minimal data are available beyond case reports. We aim to report the …

Background Preapproval trials showed that messenger RNA (mRNA)–based vaccines
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety …

Abstract Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms> 3–4
weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from …

Myocarditis is the progressive inflammation of the middle layer of the heart followed by a
myocardial injury without ischemic events [1, 2]. The infectious and non-infectious causes of …

Myocarditis is an inflammatory disease of the myocardium with focal or diffuse involvement.
Viral infections are the most common cause of myocarditis, especially in Western countries …